• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项计算研究旨在确定过氧化物酶体增殖物激活受体 γ 与其拮抗剂相互作用中的关键残基。

A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists.

机构信息

a Department of Chemistry , Isfahan University of Technology , Isfahan , Iran.

出版信息

J Biomol Struct Dyn. 2018 May;36(7):1822-1833. doi: 10.1080/07391102.2017.1335618. Epub 2017 Jun 14.

DOI:10.1080/07391102.2017.1335618
PMID:28566016
Abstract

Peroxisome proliferator-activated receptors (PPARs) compose a family of nuclear receptors, PPARα, PPARβ, and PPARγ, which mediate the effects of lipidic ligands at the transcriptional level. Among these, the PPARγ has been known to regulate adipocyte differentiation, fatty acid storage and glucose metabolism, and is a target of antidiabetic drugs. In this work, the interactions between PPARγ and its six known antagonists were investigated using computational methods such as molecular docking, molecular dynamics (MD) simulations, and the hybrid quantum mechanics/molecular mechanics (QM/MM). The binding energies evaluated by molecular docking varied between -22.59 and -35.15 kJ mol. In addition, MD simulations were performed to investigate the binding modes and PPARγ conformational changes upon binding of antagonists. Analysis of the root-mean-square fluctuations (RMSF) of backbone atoms shows that H3 of PPARγ has a higher mobility in the absence of antagonists and moderate conformational changes were observed. The interaction energies between antagonists and each PPARγ residue involved in the interactions were studied by QM/MM calculations. These calculations reveal that antagonists with different structures show different interaction energies with the same residue of PPARγ. Therefore, it can be concluded that the key residues vary depending on the structure of the ligand, which binds to PPARγ.

摘要

过氧化物酶体增殖物激活受体 (PPARs) 构成了核受体家族,包括 PPARα、PPARβ 和 PPARγ,它们在转录水平上介导脂质配体的作用。其中,PPARγ 已被证明可调节脂肪细胞分化、脂肪酸储存和葡萄糖代谢,是抗糖尿病药物的靶点。在这项工作中,使用分子对接、分子动力学 (MD) 模拟和混合量子力学/分子力学 (QM/MM) 等计算方法研究了 PPARγ 与其六个已知拮抗剂之间的相互作用。分子对接评估的结合能在 -22.59 到 -35.15 kJ/mol 之间变化。此外,还进行了 MD 模拟以研究拮抗剂结合时的结合模式和 PPARγ 构象变化。对骨架原子均方根波动 (RMSF) 的分析表明,在没有拮抗剂的情况下,PPARγ 的 H3 具有更高的迁移率,并且观察到中等程度的构象变化。通过 QM/MM 计算研究了拮抗剂与参与相互作用的每个 PPARγ 残基之间的相互作用能。这些计算表明,具有不同结构的拮抗剂与 PPARγ 相同残基的相互作用能不同。因此,可以得出结论,关键残基取决于与 PPARγ 结合的配体的结构。

相似文献

1
A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists.一项计算研究旨在确定过氧化物酶体增殖物激活受体 γ 与其拮抗剂相互作用中的关键残基。
J Biomol Struct Dyn. 2018 May;36(7):1822-1833. doi: 10.1080/07391102.2017.1335618. Epub 2017 Jun 14.
2
Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ).溶血磷脂酰胆碱 (LPC) 配体与过氧化物酶体增殖物激活受体 γ (PPARγ) 结合的激动作用活性。
J Biomol Struct Dyn. 2020 Feb;38(2):398-409. doi: 10.1080/07391102.2019.1577175. Epub 2019 Apr 26.
3
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists.对过氧化物酶体增殖物激活受体γ(PPARγ)拮抗作用的结构与动力学洞察:非共价拮抗剂配体-受体相互作用的计算机模拟研究
Int J Mol Sci. 2015 Jul 8;16(7):15405-24. doi: 10.3390/ijms160715405.
4
Computational investigation of phytochemicals from seeds as modulators of peroxisome proliferator-activated receptor gamma (PPARγ).种子中植物化学物质作为过氧化物酶体增殖物激活受体γ(PPARγ)调节剂的计算研究。
J Biomol Struct Dyn. 2023 Jul-Aug;41(12):5568-5582. doi: 10.1080/07391102.2022.2091657. Epub 2022 Jun 30.
5
Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.探究过氧化物酶体增殖物激活受体γ配体结合域(PPARγ-LBD)与多不饱和脂肪酸及其抗炎代谢产物之间的分子间相互作用,以推断最具潜力的结合部分。
Lipids Health Dis. 2017 Jan 21;16(1):17. doi: 10.1186/s12944-016-0404-3.
6
Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartan.通过替米沙坦的核心跃迁,鉴定出同时靶向血管紧张素 II 型 1 受体和过氧化物酶体增殖物激活受体-γ 的双重配体。
J Biomol Struct Dyn. 2017 Sep;35(12):2665-2680. doi: 10.1080/07391102.2016.1227726. Epub 2016 Sep 7.
7
CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands.过氧化物酶体增殖物激活受体γ配体的CHARMM力场参数化
Int J Mol Sci. 2016 Dec 22;18(1):15. doi: 10.3390/ijms18010015.
8
Homology modeling and molecular docking studies on Type II diabetes complications reduced PPARγ receptor with various ligand molecules.同源建模和分子对接研究表明,II 型糖尿病并发症降低了 PPARγ 受体与各种配体分子的结合。
Biomed Pharmacother. 2017 Aug;92:528-535. doi: 10.1016/j.biopha.2017.05.077. Epub 2017 May 30.
9
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.基于支架的 PPARα、PPARβ 和 PPARγ 受体泛激动剂设计。
PLoS One. 2012;7(10):e48453. doi: 10.1371/journal.pone.0048453. Epub 2012 Oct 31.
10
PPARγ non-covalent antagonists exhibit mutable binding modes with a similar free energy of binding: a case study.PPARγ 非共价拮抗剂表现出可变化的结合模式,具有相似的结合自由能:案例研究。
J Biomol Struct Dyn. 2017 Feb;35(3):476-485. doi: 10.1080/07391102.2016.1151830. Epub 2016 Aug 2.

引用本文的文献

1
Protective Effect of Hydroxytyrosol on LPS-Induced Inflammation and Oxidative Stress in Bovine Endometrial Epithelial Cell Line.羟基酪醇对脂多糖诱导的牛子宫内膜上皮细胞系炎症和氧化应激的保护作用
Vet Sci. 2020 Oct 23;7(4):161. doi: 10.3390/vetsci7040161.
2
To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations.利用分子动力学模拟探究泛激动剂西格列他扎对人过氧化物酶体增殖物激活受体的完全和部分激活作用
PPAR Res. 2020 Apr 1;2020:5314187. doi: 10.1155/2020/5314187. eCollection 2020.